Announce Date | 08/11/2025 |
EPS Normalized Actual | $0.19 (Miss by $-0.05) |
EPS GAAP Actual | $0.19 (Miss by $-0.05) |
Revenue Actual | $0.5852B |
Revenue Surprise | Beat by $585.2M |
Announce Date | 10/01/2025 (Pre-Market) |
EPS Normalized Estimate | $0.3 |
EPS GAAP Estimate | $0.3 |
Revenue Estimate | $0.6449B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 1.6 | 5.72 | 1.57134 | 1.63446 | 1 |
Dec 2028 | 1.65 | 5.55 | 1.63083 | 1.67021 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | -0.08 | -0.33821 | 0.5852B | 100% | -27.76M |
FQ1 2025 (Mar 2025) | -0.04 | -0.04 | 0.5798B | 100% | 579.8M |
FQ4 2024 (Dec 2024) | 0.018 | 0.018 | 0.6319B | 100% | 631.9M |
FQ3 2024 (Sep 2024) | 0.0074 | 0.0074 | 0.6091B | 100% | 609.1M |
FQ3 2012 (Sep 2012) | 1.79 | 1.79 | 0.4132B | 100% | 413.2M |
FQ4 2012 (Dec 2012) | 2.32 | 2.32 | 0.4631B | 100% | 463.1M |
FQ1 2013 (Mar 2013) | 1.32 | 1.32 | 0.381B | 100% | 381M |
FQ2 2013 (Jun 2013) | 1.48 | 1.48 | 0.3864B | 100% | 386.4M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
0.3
Consensus Revenue Estimates
0.6449B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.4213 | -- | 0.41651 | 0.42602 | 2 |
FQ3 2027 (Sep 2027) | 0.3753 | -- | 0.37103 | 0.3795 | 2 |
FQ2 2027 (Jun 2027) | 0.3441 | -- | 0.34019 | 0.34795 | 2 |
FQ1 2027 (Mar 2027) | 0.3274 | -- | 0.32368 | 0.33106 | 2 |
FQ4 2026 (Oct 2026) | 0.35 | -- | 0.34828 | 0.35189 | 1 |
FQ3 2026 (Jul 2026) | 0.31 | -- | 0.30847 | 0.31167 | 1 |
FQ2 2026 (Jun 2026) | 0.28027 | 128.54 | 0.28027 | 0.28027 | 3 |
FQ1 2026 (Mar 2026) | 0.25781 | 115.52 | 0.25781 | 0.25781 | 4 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.9B | -- | 0.89B | 0.91B | 3 |
FQ3 2027 (Sep 2027) | 0.87B | -- | 0.86B | 0.88B | 3 |
FQ2 2027 (Jun 2027) | 0.84B | -- | 0.84B | 0.85B | 3 |
FQ1 2027 (Mar 2027) | 0.82B | -- | 0.81B | 0.82B | 3 |
FQ4 2026 (Oct 2026) | 0.69B | -- | 0.69B | 0.69B | 2 |
FQ3 2026 (Jul 2026) | 0.66B | -- | 0.66B | 0.66B | 2 |
FQ2 2026 (Jun 2026) | 0.64B | 9 | 0.64B | 0.64B | 3 |
FQ1 2026 (Mar 2026) | 0.62B | 7.05 | 0.62B | 0.62B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0.25821 | -0.08 | -0.33821 | 422.76% |
FQ1 2025 (Mar 2025) | -0.04 | -0.04 | 100% | |
FQ4 2024 (Dec 2024) | 0.018 | 0.018 | 100% | |
FQ3 2024 (Sep 2024) | 0.0074 | 0.0074 | 100% | |
FQ3 2012 (Sep 2012) | 1.79 | 1.79 | 100% | |
FQ4 2012 (Dec 2012) | 2.32 | 2.32 | 100% | |
FQ1 2013 (Mar 2013) | 1.32 | 1.32 | 100% | |
FQ2 2013 (Jun 2013) | 1.48 | 1.48 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $0.61B | $0.59B | $-27.76M | -4.74% |
FQ1 2025 (Mar 2025) | $0B | $0.58B | $579.8M | 100% |
FQ4 2024 (Dec 2024) | $0B | $0.63B | $631.9M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.61B | $609.1M | 100% |
FQ3 2012 (Sep 2012) | $0B | $0.41B | $413.2M | 100% |
FQ4 2012 (Dec 2012) | $0B | $0.46B | $463.1M | 100% |
FQ1 2013 (Mar 2013) | $0B | $0.38B | $381M | 100% |
FQ2 2013 (Jun 2013) | $0B | $0.39B | $386.4M | 100% |